2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow cendakimab: new trials by email Literature Review of cendakimab trials Research Report on cendakimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis CC-93538, Placebo - Dermatitis, Atopic, Eczema | Phase 2 | Completed | Celgene | 221 | 2021-05-14 | 2024-01-03 |
| Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis RPC4046, Placebo - Eosinophilic Esophagitis | Phase 2 | Completed | Celgene | 100 | 2014-08-31 | 2017-05-09 |
Dermatitis, Atopic (1) · Eczema (1) · Eosinophilic Esophagitis (1)
Celgene (2)
Canada (2) · United States (2) · China (1) · Czechia (1) · Japan (1) · Poland (1) · Switzerland (1)